Literature DB >> 28182362

Upregulation of FoxO 1 Signaling Mediates the Proinflammatory Cytokine Upregulation in the Macrophage from Polycystic Ovary Syndrome Patients.

Ning Li, Xiaoyan Wang, Xiaojie Wang, Hongna Yu, Li Lin, Chengming Sun, Peng Liu, Yongli Chu, Jianqing Hou.   

Abstract

BACKGROUND: Chronic activation of macrophage-mediated inflammatory signals in insulin-sensitive metabolic tissues is thought to be one of the causes of insulin resistance-one of the hallmarks of the metabolic syndrome. Insulin resistance is a feature of polycystic ovary syndrome (PCOS) and is related to mitochondrial and endothelial function.
METHODS: In the present study, we investigated the phosphorylation level of FoxO 1, which is suppressed by the action of AKT, triggers the TLR4 inflammatory signaling pathway in the macrophages, from polycystic ovary syndrome patients or normal subjects. Then we investigated the influence of phosphorylation level of FoxO 1FoxO 1 on the induction of proinflammatory cytokines in the macrophages and the influence by FoxO FoxO 1 knockdown on the insulin-induced glucose uptake in PCOS macrophages.
RESULTS: Our results demonstrated that the significantly high level of FoxO 1FoxO 1 phosphorylation correlated with the production of proinflammatory cytokines, such as IL-6, IL-1β, and TNF-α in the macrophages from PCOS patients. The high level of FoxO 1FoxO 1 phosphorylation enhanced the TLR-4 signaling in response to LPS, and the FoxO FoxO 1 knockdown inhibited the insulin-induced glucose uptake in PCOS macrophages.
CONCLUSIONS: The findings of this paper suggest an intriguing regulatory transcriptional/signaling loop in macrophages that may contribute to maintain and exacerbate inflammation and insulin resistance in PCOS macrophages.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28182362     DOI: 10.7754/Clin.Lab.2016.160514

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  6 in total

1.  Detection of T lymphocyte subsets and related functional molecules in follicular fluid of patients with polycystic ovary syndrome.

Authors:  Zitao Li; Anping Peng; Yuanfa Feng; Xiaona Zhang; Fenghua Liu; Chuangqi Chen; Xin Ye; Jiale Qu; Chenxi Jin; Mei Wang; Huaina Qiu; Yanwei Qi; Jun Huang; Quan Yang
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

2.  Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.

Authors:  Ting Wang; Liping Sha; Yiwei Li; Lili Zhu; Zhen Wang; Ke Li; Haixia Lu; Ting Bao; Li Guo; Xiaoxia Zhang; Hao Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-27       Impact factor: 5.555

3.  A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome.

Authors:  Lihong Liu; Bo Du; Haiying Zhang; Xiaofei Guo; Zheng Zhou; Aihui Xiu; Chang Liu; Shiyu Su; Hao Ai
Journal:  Chin Med       Date:  2018-08-29       Impact factor: 5.455

Review 4.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

5.  Transcriptome profiling reveals new insights into the roles of neuronal nitric oxide synthase on macrophage polarization towards classically activated phenotype.

Authors:  Pingan Chang; Hao Gao; Quan Sun; Xiaohong He; Feifei Huang
Journal:  PLoS One       Date:  2021-09-29       Impact factor: 3.240

Review 6.  The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Liyun Duan; Xuedong An; Yuehong Zhang; Shenghui Zhao; Rongrong Zhou; Yingying Duan; Yuqing Zhang; Xinmin Liu; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-08       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.